Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort
Launched by UNIVERSITY HOSPITAL, BREST · Sep 21, 2018
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Brest Cohort, is studying how well different tests and evaluations can help doctors diagnose Primary Sjögren's Syndrome (pSS), a condition that affects the body's moisture-producing glands. The goal is to find out which methods work best for identifying this syndrome and understanding its progression.
To participate in this trial, individuals must be aged between 65 and 74 and have symptoms that suggest they might have pSS. It’s important to note that patients who do not wish to participate will not be included. Those who join the study can expect to undergo a standardized evaluation, which means they will be assessed using a consistent set of tests. The trial is currently looking for participants, and anyone interested should feel free to ask questions to learn more about what being part of this study involves.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with suspected pSS underwent a standardised evaluation
- Exclusion Criteria:
- • Opposition of patient
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, , France
Patients applied
Trial Officials
Valerie Devauchelle
Study Director
CHRU de Brest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials